Navigation Links
Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
Date:9/22/2008

tive Officer.

About Hypophosphatasia

Hypophosphatasia is a rare, inherited, and sometimes fatal metabolic bone disease. Patients have low levels of the tissue non-specific form of alkaline phosphatase, an important regulator of bone mineralization, leading to rickets in infants and children and osteomalacia ("soft bones" resulting from poor mineralization) in adults. Disease severity is inversely proportional to the age at symptom onset, but morbidity can be cumulative and worsen with age. Clinical severity ranges from the severe perinatal or infantile form, with profound skeletal hypomineralization and respiratory compromise often causing death, to a more slowly progressive and debilitating osteomalacia in adults.

In the infantile form, infants may appear normal at birth but develop serious symptoms in the first six months of life. These can include failure to thrive, respiratory failure, fractures, and seizures. Radiographic findings include generalized hypomineralization and rickets. Mortality in these patients may be as high as 50%. In the childhood form, patients have varying degrees of hypomineralization, frank rickets, short stature, bone pain, muscle weakness, delayed motor milestones, early loss of deciduous teeth, and may experience frequent, poorly-healing fractures. In the adult form, the underlying osteomalacia causes bone pain due to overt or poorly-healing stress fractures that in some cases stops ambulation.

About ENB-0040

ENB-0040 is a fusion protein that includes the catalytic domain of human tissue non-specific alkaline phosphatase (TNSALP), and a patented peptide used to target the enzyme to bone. Preclinical studies of ENB-0040 in the "knockout" mouse model of severe hypophosphatasia were recently published in the Journal of Bone and Mineral Research [June 2008:23:777-787] and showed that subcutaneous administration of ENB-0040 significantly improved survival and prevented the skeletal and dental manifestations
'/>"/>

SOURCE Enobia Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
2. Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia
3. Vion Pharmaceuticals Enters into Agreement to Conduct a Phase I/II Clinical Trial of Cloretazine(R) in Combination with Induction Therapy in Poor Prognosis AML Patients
4. Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th
5. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
6. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
7. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
8. VIA Pharmaceuticals to Present at American Heart Association Scientific Sessions 2008
9. Unibioscreen and Drais Pharmaceuticals Partner to Develop and Commercialize UNBS 5162 for Treatment of Cancer
10. Vanda Pharmaceuticals Provides Update on Iloperidone
11. Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... July 6, 2015 Cardinal Health today announced ... Group (THDG). A distributor of generic pharmaceuticals, over-the-counter medications and ... THDG was owned by Court Square Capital Partners. The ... cash and new debt.  Headquartered in ... Group had revenues of approximately $450 million in 2014. ...
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ) has ... Chloride Market by Applications, by Region - Industry Trends ... The pharmaceutical grade sodium chloride market is ... and 2019 in terms of volume, and the consumption ... The report on Pharmaceutical grade sodium chloride market, ...
(Date:7/6/2015)... -- Celtaxsys, Inc., a clinical stage pharmaceutical development company ... orphan inflammatory disease indications, announced today that it has ... (FDA) to begin a Phase 2 clinical trial of ... patients in the US. The regulatory submissions to the ... be filed soon after. This groundbreaking clinical study, testing ...
Breaking Medicine Technology:Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 2Cardinal Health Completes Acquisition Of The Harvard Drug Group For $1.115 Billion 3Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3
(Date:7/6/2015)... Utah (PRWEB) , ... July 06, 2015 , ... doTERRA, ... Jowers to its executive management team. Most recently, Jowers held the position as Director ... ten years. , After spending a decade building the institute, Jowers states that he ...
(Date:7/6/2015)... ... 06, 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO of ... Seedstock Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be held ... of California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs are ...
(Date:7/6/2015)... ... , ... MD Now, the leading and fastest-growing urgent care provider in Florida, ... will serve residents and visitors in the Cutler Bay area, giving them convenient access ... location, the new facility will be the fourth to serve Miami-Dade County. Located at ...
(Date:7/6/2015)... ... July 06, 2015 , ... The School of ... to support a three-year effort to reduce rates of diabetes and cardiovascular disease ... partnership with the Morehouse School of Medicine’s Prevention Research Center and the Satcher ...
(Date:7/6/2015)... Pompano Beach, Florida (PRWEB) , ... July 06, ... ... call center solutions, announced today that Randstad Technologies selected Aspect Software Unified IP ... provider in the United States, selected Aspect Unified IP as its future call ...
Breaking Medicine News(10 mins):Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3
... 6 (HealthDay News) -- A large, national study on how ... people,s understanding about the risks was announced Thursday by the ... of Health. Researchers will follow more than 40,000 people, ... products or are at risk. The study goals include: ...
... HealthDay Reporter , THURSDAY, Oct. 6 (HealthDay News) -- Indoor tanning ... previously believed. New research published online Oct. 6 in the ... of ultraviolet rays used in tanning beds -- UVA1 -- may ... to the cancer-causing changes caused by UV rays. ...
... According to Anna R. Giuliano, Ph.D., program leader in ... colleagues in the Netherlands, earlier circumcision of males in South ... of both HIV and the human papillomavirus (HPV). Their commentary ... British medical journal The Lancet Infectious Diseases (Vol. ...
... Thomas Jefferson University biochemistry researchers have shown for ... molting hormone doesn,t activate and repress genes as once thought. ... by a heme-binding receptor to repress the same genes during ... For the last 20 years, the nuclear receptor known as ...
... (HealthDay News) -- More than 28,000 cases of injury and ... occurred in the United States between 2002 and 2008, according ... occurred at private homes, and the most common problems were ... The findings are based on projections from a nationally ...
... Amanda Gardner HealthDay Reporter , THURSDAY, Oct. 6 (HealthDay ... plans have inpatient surgery in the last year of their life, ... whether such surgery is necessary or not is a tricky one ... patient,s family, said Dr. Frank Opelka, an associate medical director at ...
Cached Medicine News:Health News:National Study Will Track Tobacco Use in U.S. 2Health News:Tanning Beds May Be Even Riskier Than Thought 2Health News:Tanning Beds May Be Even Riskier Than Thought 3Health News:Earlier male circumcision may help to slow rates of HIV, HPV transmission in South Africa 2Health News:Nuclear receptors battle it out during metamorphosis in new fruit fly model 2Health News:Many Medicare Patients Get Surgeries in Last Year of Life: Study 2
... ring electrodes feature a molded grip ... slider that moves smoothly and locks ... also feature ultraflexible, red-and-black, 61-cm (24-in) ... resistance of bend-relief protection at both ...
... bars made of silver/silver chloride have contacts ... easy separation into two individual tabs. For ... 17). Bar dimensions: 4 cm (1.6 in) ... 200-count package contains 50 individually sealed sets ...
... Video Camera System (NTSC)With Maxenon PowerPlus ... surgeon's eye view of any procedure. ... or digital files for later use. ... 8" to 36". Automatic Iris and ...
... and your patient warm, with the ... system.,Designed around the Coanda Effect, thousands ... air flow around your torso's blush ... the heat and stress induced environment ...
Medicine Products: